|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
multiple interactions increases expression |
ISO |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of ACSL1 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Promegestone results in increased phosphorylation of AKT1 protein fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein]; Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16020483 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Ap1g1 |
adaptor related protein complex 1 subunit gamma 1 |
multiple interactions |
ISO |
[Promegestone co-treated with methoxyacetic acid] results in increased expression of AP1G1 mRNA |
CTD |
PMID:15103026 |
|
NCBI chr19:41,805,252...41,860,076
|
|
G |
Ar |
androgen receptor |
affects binding |
EXP |
Promegestone binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Areg |
amphiregulin |
multiple interactions |
ISO |
[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein; [Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK3 protein; Gefitinib inhibits the reaction [[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein]; Gefitinib inhibits the reaction [[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21258428 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
multiple interactions |
ISO |
Promegestone promotes the reaction [ARID1A protein binds to PGR protein] |
CTD |
PMID:19609353 |
|
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
Promegestone results in increased expression of CCND1 mRNA |
CTD |
PMID:19609353 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of CYP26A1 mRNA [Promegestone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA |
CTD |
PMID:16955405 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Dlg5 |
discs large MAGUK scaffold protein 5 |
multiple interactions increases expression |
ISO |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of DLG5 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr15:120,213...230,312
Ensembl chr15:120,372...228,977
|
|
G |
Elf5 |
E74 like ETS transcription factor 5 |
increases expression |
ISO |
Promegestone results in increased expression of ELF5 protein |
CTD |
PMID:20519331 |
|
NCBI chr 3:93,333,514...93,374,454
Ensembl chr 3:93,351,619...93,371,656
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of FOS mRNA SMARCA2 protein affects the reaction [Promegestone results in increased expression of FOS mRNA]; SMARCA4 protein affects the reaction [Promegestone results in increased expression of FOS mRNA] |
CTD |
PMID:19609353 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions increases expression |
ISO |
PGR protein promotes the reaction [Promegestone results in increased expression of FSHB mRNA] |
CTD |
PMID:16675544 |
|
NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of GLUL mRNA methoxyacetic acid promotes the reaction [Promegestone results in increased expression of GLUL mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
|
|
G |
Gpsm2 |
G-protein signaling modulator 2 |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of GPSM2 mRNA methoxyacetic acid promotes the reaction [Promegestone results in increased expression of GPSM2 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr 2:211,480,120...211,528,096
Ensembl chr 2:211,480,400...211,527,919
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
ISO |
mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]]; mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]]; Promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]; Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter] |
CTD |
PMID:16807381 |
|
NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression |
ISO |
Promegestone results in decreased expression of LHB mRNA |
CTD |
PMID:16675544 |
|
NCBI chr 1:101,409,992...101,413,725
Ensembl chr 1:101,410,019...101,413,724
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein]; Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] [Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein; Gefitinib inhibits the reaction [[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein]; Gefitinib inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:16020483 PMID:21258428 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
Fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of MAPK3 protein]; Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK3 protein] [Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK3 protein; gefitinib inhibits the reaction [[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK3 protein]; gefitinib inhibits the reaction [Promegestone results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16020483 PMID:21258428 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mt2A |
metallothionein 2A |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of MT2A mRNA methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MT2A mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions increases expression |
ISO |
SMARCA2 protein affects the reaction [Promegestone results in increased expression of MYC mRNA]; SMARCA4 protein affects the reaction [Promegestone results in increased expression of MYC mRNA] |
CTD |
PMID:19609353 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Myo10 |
myosin X |
multiple interactions increases expression |
ISO |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MYO10 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr 2:77,868,398...78,072,443
Ensembl chr 2:77,868,412...78,071,309
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases phosphorylation |
ISO |
Promegestone results in increased phosphorylation of NR3C1 protein |
CTD |
PMID:18483179 |
|
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
|
|
G |
Pgr |
progesterone receptor |
multiple interactions affects binding increases uptake affects localization increases activity |
ISO EXP |
1,1-bis(4-hydroxyphenyl)cyclohexane inhibits the reaction [Promegestone results in increased activity of PGR protein]; Bortezomib inhibits the reaction [Promegestone results in increased activity of PGR protein]; carfilzomib inhibits the reaction [Promegestone results in increased activity of PGR protein]; Decitabine inhibits the reaction [Promegestone results in increased activity of PGR protein]; fenpyroximate inhibits the reaction [Promegestone results in increased activity of PGR protein]; fluoxastrobin inhibits the reaction [Promegestone results in increased activity of PGR protein]; kresoxim-methyl inhibits the reaction [Promegestone results in increased activity of PGR protein]; methoxyacetic acid promotes the reaction [Promegestone results in increased activity of PGR protein]; metoprine inhibits the reaction [Promegestone results in increased activity of PGR protein]; Mifepristone inhibits the reaction [methoxyacetic acid promotes the reaction [Promegestone results in increased activity of PGR protein]]; picoxystrobin inhibits the reaction [Promegestone results in increased activity of PGR protein]; Proflavine inhibits the reaction [Promegestone results in increased activity of PGR protein]; Promegestone promotes the reaction [ARID1A protein binds to PGR protein]; Promegestone promotes the reaction [SMARCE1 protein binds to PGR protein]; pyrachlostrobin inhibits the reaction [Promegestone results in increased activity of PGR protein]; pyridaben inhibits the reaction [Promegestone results in increased activity of PGR protein]; Rotenone inhibits the reaction [Promegestone results in increased activity of PGR protein]; ST 1481 inhibits the reaction [Promegestone results in increased activity of PGR protein]; trifloxystrobin inhibits the reaction [Promegestone results in increased activity of PGR protein]; U 0126 inhibits the reaction [methoxyacetic acid promotes the reaction [Promegestone results in increased activity of PGR protein]]; Vorinostat inhibits the reaction [Promegestone results in increased activity of PGR protein]; ZNF366 protein inhibits the reaction [Promegestone results in increased activity of PGR protein] Promegestone binds to PGR protein PGR protein results in increased uptake of Promegestone PGR protein promotes the reaction [Promegestone results in increased expression of FSHB mRNA] Promegestone affects the localization of PGR protein |
CTD |
PMID:15103026 PMID:16020483 PMID:16675544 PMID:18486176 PMID:19609353 PMID:20008677 PMID:21795739 PMID:23765520 PMID:30818834 PMID:30951782 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Qsox1 |
quiescin sulfhydryl oxidase 1 |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of QSOX1 mRNA methoxyacetic acid promotes the reaction [Promegestone results in increased expression of QSOX1 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr13:73,423,396...73,460,890
Ensembl chr13:73,423,397...73,460,935
|
|
G |
Rbbp7 |
RB binding protein 7, chromatin remodeling factor |
multiple interactions increases expression |
ISO |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of RBBP7 mRNA] |
CTD |
PMID:15103026 |
|
NCBI chr X:33,648,682...33,665,821
Ensembl chr X:33,648,682...33,665,821
|
|
G |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
multiple interactions |
ISO |
SMARCA2 protein affects the reaction [Promegestone results in increased expression of FOS mRNA]; SMARCA2 protein affects the reaction [Promegestone results in increased expression of MYC mRNA] |
CTD |
PMID:19609353 |
|
NCBI chr 1:244,615,811...244,783,736
Ensembl chr 1:244,615,821...244,782,706
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
multiple interactions |
ISO |
SMARCA4 protein affects the reaction [Promegestone results in increased expression of FOS mRNA]; SMARCA4 protein affects the reaction [Promegestone results in increased expression of MYC mRNA] |
CTD |
PMID:19609353 |
|
NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468
|
|
G |
Smarce1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
multiple interactions |
ISO |
Promegestone promotes the reaction [SMARCE1 protein binds to PGR protein] |
CTD |
PMID:19609353 |
|
NCBI chr10:87,116,827...87,138,890
Ensembl chr10:87,116,827...87,137,965
|
|
G |
Sp1 |
Sp1 transcription factor |
increases expression multiple interactions |
ISO |
Promegestone results in increased expression of SP1 mRNA; Promegestone results in increased expression of SP1 protein mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]]; Promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter] |
CTD |
PMID:16807381 |
|
NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
|
|
G |
Sp3 |
Sp3 transcription factor |
multiple interactions increases expression |
ISO |
mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]]; Promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter] Promegestone results in increased expression of SP3 mRNA; Promegestone results in increased expression of SP3 protein |
CTD |
PMID:16807381 |
|
NCBI chr 3:59,644,579...59,689,011
Ensembl chr 3:59,646,015...59,688,692
|
|
G |
Tigar |
TP53 induced glycolysis regulatory phosphatase |
multiple interactions |
ISO |
[Promegestone co-treated with methoxyacetic acid] results in increased expression of TIGAR mRNA |
CTD |
PMID:15103026 |
|
NCBI chr 4:159,635,145...159,654,108
Ensembl chr 4:159,635,153...159,654,063
|
|
G |
Vdr |
vitamin D receptor |
increases expression |
ISO |
Promegestone results in increased expression of VDR protein |
CTD |
PMID:7662588 |
|
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
G |
Zfp366 |
zinc finger protein 366 |
multiple interactions |
ISO |
ZNF366 protein inhibits the reaction [Promegestone results in increased activity of PGR protein] |
CTD |
PMID:20008677 |
|
NCBI chr 2:29,410,169...29,498,661
Ensembl chr 2:29,410,579...29,498,664
|
|
G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
multiple interactions |
ISO |
[Promegestone co-treated with Estradiol] results in increased expression of ZFP36L1 mRNA |
CTD |
PMID:19146866 |
|
NCBI chr 6:103,308,032...103,313,074
Ensembl chr 6:103,308,045...103,313,074
|
|